THANK YOU FOR SUBSCRIBING

Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care.

Hackensack University Medical Center was the first hospital in the U.S. to perform procedures using the Impella 5.5 and is involved in pioneering research and advanced clinical trials.

As science surges ahead, many question whether the artistry of medicine is a forgotten practice. This is an exciting time, redefining the limits of human dexterity.

As we encourage patients to take more ownership of their healthcare, and encourage adherence, we must support continued development of new technologies and patient engagement methods.

Data and analytics will be central in ensuring we can look beyond the surface to create that value for patients and providers.

It’s no surprise that technology advances continue to help us reduce costs and meet customer demand in every industry that has a supply chain.

The word “transformational” is frequently used by eClinical solution vendors and clinical trials professionals to describe platforms, solutions and applications of technology.

The utilization of advanced technology to modulate the central or peripheral nervous system in patients with neurological disorders has expanded significantly over the past three decades.

According to the American Heart Association, someone in the United States, where ischemic stroke is a leading cause of death, has a stroke about every 40 seconds.

Doing things to people rather than with and for them results in unwarranted suffering, decreased quality of life and even death.